協和キリンの株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2013/05/17 | 1,226 | 1,229 | 1,208 | 1,226 | ±0 | ±0% | 1,311,000 |
| 2013/05/16 | 1,246 | 1,250 | 1,214 | 1,226 | -26 | -2.1% | 1,569,000 |
| 2013/05/15 | 1,248 | 1,256 | 1,242 | 1,252 | +17 | +1.4% | 1,099,000 |
| 2013/05/14 | 1,247 | 1,247 | 1,235 | 1,235 | -7 | -0.6% | 876,000 |
| 2013/05/13 | 1,250 | 1,250 | 1,230 | 1,242 | +5 | +0.4% | 1,211,000 |
| 2013/05/10 | 1,242 | 1,250 | 1,228 | 1,237 | +28 | +2.3% | 1,590,000 |
| 2013/05/09 | 1,241 | 1,249 | 1,207 | 1,209 | -26 | -2.1% | 894,000 |
| 2013/05/08 | 1,220 | 1,250 | 1,214 | 1,235 | +23 | +1.9% | 1,791,000 |
| 2013/05/07 | 1,186 | 1,213 | 1,180 | 1,212 | +53 | +4.6% | 1,613,000 |
| 2013/05/02 | 1,171 | 1,172 | 1,153 | 1,159 | -11 | -0.9% | 895,000 |
| 2013/05/01 | 1,174 | 1,195 | 1,148 | 1,170 | -25 | -2.1% | 1,237,000 |
| 2013/04/30 | 1,198 | 1,205 | 1,183 | 1,195 | -5 | -0.4% | 1,727,000 |
| 2013/04/26 | 1,205 | 1,213 | 1,192 | 1,200 | +3 | +0.3% | 1,281,000 |
| 2013/04/25 | 1,198 | 1,203 | 1,183 | 1,197 | +7 | +0.6% | 1,839,000 |
| 2013/04/24 | 1,201 | 1,204 | 1,162 | 1,190 | -9 | -0.8% | 2,496,000 |
| 2013/04/23 | 1,196 | 1,200 | 1,192 | 1,199 | +2 | +0.2% | 881,000 |
| 2013/04/22 | 1,185 | 1,206 | 1,184 | 1,197 | +23 | +2% | 1,350,000 |
| 2013/04/19 | 1,165 | 1,178 | 1,157 | 1,174 | +15 | +1.3% | 1,089,000 |
| 2013/04/18 | 1,169 | 1,170 | 1,151 | 1,159 | -9 | -0.8% | 1,172,000 |
| 2013/04/17 | 1,154 | 1,168 | 1,146 | 1,168 | +13 | +1.1% | 1,785,000 |
| 2013/04/16 | 1,125 | 1,160 | 1,120 | 1,155 | +13 | +1.1% | 1,193,000 |
| 2013/04/15 | 1,145 | 1,155 | 1,136 | 1,142 | -3 | -0.3% | 1,204,000 |
| 2013/04/12 | 1,158 | 1,162 | 1,138 | 1,145 | +3 | +0.3% | 2,757,000 |
| 2013/04/11 | 1,153 | 1,168 | 1,132 | 1,142 | -11 | -1% | 2,155,000 |
| 2013/04/10 | 1,130 | 1,163 | 1,127 | 1,153 | +27 | +2.4% | 2,217,000 |
| 2013/04/09 | 1,122 | 1,127 | 1,108 | 1,126 | -2 | -0.2% | 1,844,000 |
| 2013/04/08 | 1,122 | 1,135 | 1,110 | 1,128 | +25 | +2.3% | 1,307,000 |
| 2013/04/05 | 1,130 | 1,138 | 1,099 | 1,103 | -1 | -0.1% | 2,025,000 |
| 2013/04/04 | 1,054 | 1,105 | 1,042 | 1,104 | +39 | +3.7% | 2,536,000 |
| 2013/04/03 | 1,042 | 1,065 | 1,035 | 1,065 | +31 | +3% | 1,231,000 |
| 2013/04/02 | 1,050 | 1,050 | 1,006 | 1,034 | -24 | -2.3% | 1,474,000 |
| 2013/04/01 | 1,080 | 1,085 | 1,056 | 1,058 | -16 | -1.5% | 2,171,000 |
| 2013/03/29 | 1,071 | 1,079 | 1,066 | 1,074 | +10 | +0.9% | 1,263,000 |
| 2013/03/28 | 1,083 | 1,086 | 1,061 | 1,064 | -25 | -2.3% | 2,041,000 |
| 2013/03/27 | 1,083 | 1,090 | 1,071 | 1,089 | +16 | +1.5% | 1,233,000 |
| 2013/03/26 | 1,070 | 1,081 | 1,066 | 1,073 | -3 | -0.3% | 1,315,000 |
| 2013/03/25 | 1,080 | 1,083 | 1,071 | 1,076 | +16 | +1.5% | 1,185,000 |
| 2013/03/22 | 1,079 | 1,089 | 1,057 | 1,060 | -19 | -1.8% | 1,749,000 |
| 2013/03/21 | 1,054 | 1,079 | 1,039 | 1,079 | +24 | +2.3% | 2,398,000 |
| 2013/03/19 | 1,033 | 1,057 | 1,033 | 1,055 | +36 | +3.5% | 1,922,000 |
| 2013/03/18 | 1,025 | 1,036 | 1,018 | 1,019 | -25 | -2.4% | 1,560,000 |
| 2013/03/15 | 1,007 | 1,044 | 1,004 | 1,044 | +45 | +4.5% | 2,630,000 |
| 2013/03/14 | 988 | 1,000 | 983 | 999 | +11 | +1.1% | 969,000 |
| 2013/03/13 | 987 | 998 | 984 | 988 | -12 | -1.2% | 1,052,000 |
| 2013/03/12 | 1,004 | 1,011 | 1,000 | 1,000 | -4 | -0.4% | 1,627,000 |
| 2013/03/11 | 1,000 | 1,012 | 996 | 1,004 | +9 | +0.9% | 1,379,000 |
| 2013/03/08 | 987 | 997 | 980 | 995 | +11 | +1.1% | 4,900,000 |
| 2013/03/07 | 990 | 996 | 976 | 984 | -3 | -0.3% | 1,702,000 |
| 2013/03/06 | 970 | 987 | 970 | 987 | +18 | +1.9% | 1,275,000 |
| 2013/03/05 | 978 | 980 | 965 | 969 | ±0 | ±0% | 809,000 |
3001～
3050
件表示中 / 3768件
類似銘柄と比較する
現在ご覧いただいている「協和キリン」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| 協和キリン | 263,900円 | -3.5% | -11.3% | 2.27% | 24.24倍 | 1.64倍 |
|
キリン傘下。医薬品、バイオが主力。独自の抗体高活性化技術に強み。富士フイルムと提携 |
| アステラス薬 | 169,200円 | +0.9% | +380.2% | 4.61% | 23.31倍 | 2.00倍 |
|
医薬品国内２位。開発技術起点の研究開発体制。前立腺がん薬が柱。遺伝子・細胞治療技術育成 |
| 塩野義 | 258,000円 | +20.9% | +10.6% | 2.56% | 12.20倍 | 1.61倍 |
|
抗ＨＩＶ薬が大型製品に。感染症、疼痛・中枢神経領域に強み。米国に積極展開。欧州、アジア開拓 |
| エーザイ | 467,600円 | +0.1% | -3.4% | 3.42% | 31.79倍 | 1.57倍 |
|
神経系、がん領域に強み。認知症薬は米バイオジェンと、抗がん薬では米メルクと国際協業推進 |
| 小野薬 | 166,100円 | +0.6% | +43.3% | 4.82% | 11.65倍 | 1.00倍 |
|
医療用医薬品専業の中堅。自社開発品多い。先駆的がん免疫阻害剤「オプジーボ」が成長牽引 |
市場注目の銘柄
チャート関連のコラム
